UNSPSC 51433202: Darusentan

This classification denotes an endothelin receptor antagonist and antihypertensive agent with the molecular formula C22H22N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33JD57L6RW, chemically known as benzenepropanoic acid, alpha-((4,6-dimethoxy-2-pyrimidinyl)oxy)-beta-methoxy-beta-phenyl-, (s)- but generally known as darusentan, which bears US NIH Compound Identifier 177236. European Medicines Agency schedules Darusentan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32910.

UNSPSC 51433202 Darusentan is a Commodity code representing emergency medical medications procured by state and local public safety agencies, though the recent solicitation activity under this code shows minimal direct alignment with darusentan itself. The City of Tampa's Purchasing Department posted an IFB for Advanced Life Support Medications (Bid No. 26-P-00188) intended for use by Tampa Fire Rescue, specifying four medication line items: Labetalol HCI, Epinephrine, Adenosine, and Diltiazem. State and local governments purchase emergency pharmaceuticals under this code primarily through fire departments, emergency medical services, and hospital systems operated by municipal and county authorities. The Tampa procurement is structured as a firm-price, one-year contract with two one-year renewal options plus up to three 30-day unilateral extensions, with all medications required to maintain a nine-month minimum shelf life from acceptance and delivery within ten calendar days of order receipt. The solicitation includes a 5 percent bid discount for Small Local Business Enterprise (SLBE) participation, capped at $10,000, and requires vendors to provide Safety Data Sheets compliant with OSHA standards and accessibility documentation demonstrating WCAG 2.2 Level AA conformance.

Activity under this code is sparse in recent state and local procurement records. The Tampa Fire Rescue bid represents the only documented recent opportunity; it was posted April 24, 2026, with an electronic bid submission deadline of 3:00 pm on April 8, 2026, and carried an estimated contract value of $40,000.00, with award to be made within 120 days of bid opening. The mismatch between the code's nominal focus on darusentan and Tampa's broader Advanced Life Support Medications solicitation suggests that state and local procurement systems may tag emergency pharmaceutical buys with this commodity code even when darusentan is not explicitly itemized. Geographic activity is limited to Florida in recent records. Vendors pursuing this space should monitor fire departments and municipal EMS procurement channels in Florida and similar jurisdictions, anticipate SLBE incentives and accessibility compliance requirements, and manage expiration-date logistics carefully given the nine-month shelf-life constraint.